Style | Citing Format |
---|---|
MLA | Gholaminejad A, et al.. "Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents." BMC Nephrology, vol. 22, no. 1, 2021, pp. -. |
APA | Gholaminejad A, Gheisari Y, Jalali S, Roointan A (2021). Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents. BMC Nephrology, 22(1), -. |
Chicago | Gholaminejad A, Gheisari Y, Jalali S, Roointan A. "Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents." BMC Nephrology 22, no. 1 (2021): -. |
Harvard | Gholaminejad A et al. (2021) 'Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents', BMC Nephrology, 22(1), pp. -. |
Vancouver | Gholaminejad A, Gheisari Y, Jalali S, Roointan A. Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents. BMC Nephrology. 2021;22(1):-. |
BibTex | @article{ author = {Gholaminejad A and Gheisari Y and Jalali S and Roointan A}, title = {Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents}, journal = {BMC Nephrology}, volume = {22}, number = {1}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Gholaminejad A AU - Gheisari Y AU - Jalali S AU - Roointan A TI - Comprehensive Analysis of Iga Nephropathy Expression Profiles: Identification of Potential Biomarkers and Therapeutic Agents JO - BMC Nephrology VL - 22 IS - 1 SP - EP - PY - 2021 ER - |